Huntleys in its May 20th edition of its stock review publication, has again hit the nail on the head with the potential of the Ultra Sonic Cardiac Output Monitor.
They are big followers of this stock and obviosly see the potential of the company's current commercialisation program.
They conclude their article with what I consider to be a conservative valuation on the stock, which is more than double the current share price. The valuation allows for a 2000 monitor sales per annum worldwide with a P/E OF 10 times.
Have a read of the article and do your own research.
I believe this company has huge potential in the short to medium term.
Watch this space.
Huntleys in its May 20th edition of its stock review...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add UCM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.506M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150000 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.12pm 29/11/2024 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable
